Greykasell Wealth Strategies Inc. Acquires New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Greykasell Wealth Strategies Inc. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,583 shares of the healthcare conglomerate’s stock, valued at approximately $1,307,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Catalyst Funds Management Pty Ltd purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $556,000. Buckley Wealth Management LLC increased its holdings in UnitedHealth Group by 1.8% during the fourth quarter. Buckley Wealth Management LLC now owns 3,334 shares of the healthcare conglomerate’s stock valued at $1,687,000 after buying an additional 58 shares during the last quarter. HMV Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $939,000. Capital Management Associates NY increased its stake in shares of UnitedHealth Group by 187.0% in the fourth quarter. Capital Management Associates NY now owns 3,455 shares of the healthcare conglomerate’s stock worth $1,748,000 after purchasing an additional 2,251 shares in the last quarter. Finally, Wellington Shields & Co. LLC increased its stake in shares of UnitedHealth Group by 17.6% in the fourth quarter. Wellington Shields & Co. LLC now owns 241 shares of the healthcare conglomerate’s stock worth $122,000 after purchasing an additional 36 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $488.52 on Friday. The firm has a 50-day moving average price of $511.36 and a 200-day moving average price of $550.33. The firm has a market capitalization of $446.85 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Stephens raised their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.